The ASX 200 finished 0.36% higher in Monday trade, as the Information Technology sector and the Consumer Discretionary sector both outperformed with gains more more than 1%.

Across the commodities complex, the gold majors found demand with steady gains in Monday trade, outperforming BHP and Rio which edged lower (while Fortescue gained ground with a 1.16% rise.

Biotech stocks also had a strong session, as the ASX 200 Health Care index rose by 1.21% — its first intraday gain since last Tuesday.

Elsewhere, ASX 200 Financials stocks traded flat as investors reassess the outlook for banks and insurers in an environment of rising inflation.

Oil & gas stocks also lagged, with the ASX 200 Energy index finishing 0.19% lower.

BIG CAP WINNERS

Swipe or scroll to reveal the full table. Click headings to sort.

Code Name Price % Change Volume Market Cap
MSB Mesoblast Limited 1.9 12% 9,887,591 $1,102,783,319
ASM Ausstratmaterials 13.5 10% 892,119 $1,715,923,874
ZIM Zimplats Holding Ltd 25.52 10% 23,998 $2,504,728,092
DUB Dubber Corp Ltd 3.8 6% 1,576,736 $1,065,647,592
AVZ AVZ Minerals Ltd 0.555 6% 17,848,340 $1,689,540,657
RMD ResMed Inc. 36.7 5% 1,597,465 $14,166,940,597
LTR Liontown Resources 1.645 5% 13,502,233 $3,000,550,060
360 Life360 Inc. 13.16 4% 323,415 $1,967,615,171
NXT Nextdc Limited 12.17 4% 1,794,068 $5,338,290,439
IPL Incitec Pivot 3.24 4% 21,290,529 $6,059,742,090
MP1 Megaport Limited 21.51 4% 520,106 $3,270,983,997
PME Pro Medicus Limited 60.99 4% 138,601 $6,145,222,246
PPK PPK Group Limited 12.45 4% 119,520 $1,073,257,302
FPH Fisher & Paykel H. 30.8 4% 402,410 $17,165,434,286
MIN Mineral Resources. 41.17 3% 2,193,000 $7,523,792,406
APX Appen Limited 11.2 3% 749,129 $1,334,132,089
NIC Nickel Mines Limited 1.1 3% 12,996,433 $2,678,505,939
NAN Nanosonics Limited 6 3% 485,371 $1,752,872,904

The biggest mover among the larger caps was $1.1bn biotech Mesoblast (ASX:MSB), which has struggled for traction since the US FDA asked it to conduct another study of its stem cell treatment for children with a complication from bone marrow transplants in October 2020.

Today, the dual-listed company (Nasdaq:MESO) jumped more than 10% after presenting details of a controlled Phase 3 trial of its rexlemestrocel-L treatment in 565 patients with heart issues.

The trial results indicated a “reduction in cardiovascular mortality, heart attacks and strokes, with greatest effect seen in setting of inflammation”, MSB said.

Also performing strongly was $3bn lithium play Liontown Resources (ASX:LTR), which issued a response to a media article concerning the procurement of funding for its Kathleen Valley lithium project.

LTR said it’s “progressing a range of funding options but has not yet determined the preferred mechanism, quantum or timing of funding for Kathleen Valley and it does not have in place any mandate to raise equity”.

BIG CAP LOSERS

Swipe or scroll to reveal the full table. Click headings to sort.

Code Name Price % Change Volume Market Cap
BRN Brainchip Ltd 0.55 -9% 30,502,922 $1,024,408,472
APM APM Human Services 3.1 -7% 5,130,741 $2,992,409,205
CRN Coronado Global Res 1.235 -4% 1,809,638 $2,154,243,043
PEB Pacific Edge 1.33 -4% 1,629 $1,116,986,965
TPW Temple & Webster Ltd 10.49 -3% 1,146,952 $1,308,118,798
TLX Telix Pharmaceutical 6.65 -3% 256,593 $1,952,749,420
CXL Calix Limited 7.14 -3% 603,085 $1,181,827,302
INR Ioneer Ltd 0.72 -3% 7,882,734 $1,517,044,136
HGH Heartland Group 2.24 -3% 4,655 $1,356,619,306
YAL Yancoal Aust Ltd 2.65 -3% 186,102 $3,591,595,269
UWL Uniti Group Ltd 3.94 -2% 1,315,558 $2,779,294,879
MGH Maas Group Holdings 4.48 -2% 201,485 $1,279,796,744